(Q54663107)

2 June 2018

title

Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. (English)

1 reference

2 June 2018

main subject

Salivary duct carcinoma

1 reference

Michael Jaehne

1

1 reference

2 June 2018

Kerstin Roeser

2

1 reference

2 June 2018

Thorsten Jaekel

3

1 reference

2 June 2018

Jan David Schepers

4

1 reference

2 June 2018

Natalie Albert

5

1 reference

2 June 2018

Thomas Löning

6

1 reference

2 June 2018

language of work or name

English

0 references

publication date

1 June 2005

1 reference

2 June 2018

published in

Cancer

1 reference

2 June 2018

volume

103

1 reference

2 June 2018

issue

12

1 reference

2 June 2018

page(s)

2526-2533

1 reference

2 June 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

c-erbB-2/neu oncogene and Ki-67 analysis in the assessment of palatal salivary gland neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

p16/MTS1 inactivation in ovarian carcinomas: high frequency of reduced protein expression associated with hyper-methylation or mutation in endometrioid and mucinous tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Germline p16 mutations in familial melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Covariance analysis of censored survival data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Salivary duct carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Salivary duct carcinoma: clinical characteristics and treatment strategies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Salivary gland malignant myoepithelioma: a clinicopathologic and immunohistochemical study of ten cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Tumour growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Salivary duct carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Epithelial-myoepithelial carcinoma of salivary glands. A clinicopathologic, DNA flow cytometric, and immunohistochemical study of Ki-67 and HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Proliferating cell nuclear antigen and c-erbB-2 oncoprotein expression in adenoid cystic carcinomas of the salivary glands

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Coexpression of p53 and c-erbB-2 proteins is associated with histological type, tumour stage, and cell proliferation in malignant salivary gland tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Salivary duct carcinoma--a highly aggressive salivary gland tumour with overexpression of c-erbB-2

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumour.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Growth suppression by p16ink4 requires functional retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Inhibition of ras-induced proliferation and cellular transformation by p16INK4.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Deletion of the p16 gene and microsatellite instability in carcinoma arising in pleomorphic adenoma of the parotid gland

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21116

7 January 2021

Identifiers

DOI

10.1002/CNCR.21116

1 reference

2 June 2018

1 reference

2 June 2018